These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 1702221)
21. Molecular analysis of human acatalasemia. Identification of a splicing mutation. Wen JK; Osumi T; Hashimoto T; Ogata M J Mol Biol; 1990 Jan; 211(2):383-93. PubMed ID: 2308162 [TBL] [Abstract][Full Text] [Related]
22. Analysis of cells harboring a putative DNA repair gene reveals a lack of evidence for a second independent xeroderma pigmentosum group A correcting gene. Jones CJ; Lloyd RS; Wood RD Mutat Res; 1994 Aug; 324(4):159-64. PubMed ID: 7519740 [TBL] [Abstract][Full Text] [Related]
23. Prenatal diagnosis of xeroderma pigmentosum group A in Japan. Moriwaki S; Yamashita Y; Nakamura S; Fujita D; Kohyama J; Takigawa M; Ohmichi M J Dermatol; 2012 Jun; 39(6):516-9. PubMed ID: 22168765 [TBL] [Abstract][Full Text] [Related]
24. Allelic heterogeneity in group A xeroderma pigmentosum. Mimaki T; Tanaka K; Okada Y; Minami R; Tachi N; Nagai A; Mino M Acta Neurol Scand; 1992 May; 85(5):327-30. PubMed ID: 1621494 [TBL] [Abstract][Full Text] [Related]
25. Two mutations remote from an exon/intron junction in the beta-hexosaminidase beta-subunit gene affect 3'-splice site selection and cause Sandhoff disease. Fujimaru M; Tanaka A; Choeh K; Wakamatsu N; Sakuraba H; Isshiki G Hum Genet; 1998 Oct; 103(4):462-9. PubMed ID: 9856491 [TBL] [Abstract][Full Text] [Related]
26. Mutations in the XPD gene leading to xeroderma pigmentosum symptoms. Kobayashi T; Kuraoka I; Saijo M; Nakatsu Y; Tanaka A; Someda Y; Fukuro S; Tanaka K Hum Mutat; 1997; 9(4):322-31. PubMed ID: 9101292 [TBL] [Abstract][Full Text] [Related]
27. Clinical, cellular, and molecular features of an Israeli xeroderma pigmentosum family with a frameshift mutation in the XPC gene: sun protection prolongs life. Slor H; Batko S; Khan SG; Sobe T; Emmert S; Khadavi A; Frumkin A; Busch DB; Albert RB; Kraemer KH J Invest Dermatol; 2000 Dec; 115(6):974-80. PubMed ID: 11121128 [TBL] [Abstract][Full Text] [Related]
28. Compound heterozygosity for the Xeroderma pigmentosum complementation group A gene associated with a mild phenotype. Negishi I; Kato G; Moriwaki S; Ishikawa O Eur J Dermatol; 2002; 12(6):536-9. PubMed ID: 12459522 [TBL] [Abstract][Full Text] [Related]
29. Xeroderma pigmentosum group C splice mutation associated with autism and hypoglycinemia. Khan SG; Levy HL; Legerski R; Quackenbush E; Reardon JT; Emmert S; Sancar A; Li L; Schneider TD; Cleaver JE; Kraemer KH J Invest Dermatol; 1998 Nov; 111(5):791-6. PubMed ID: 9804340 [TBL] [Abstract][Full Text] [Related]
30. Aberrant splicing and truncated-protein expression due to a newly identified XPA gene mutation. Sato M; Nishigori C; Yagi T; Takebe H Mutat Res; 1996 Feb; 362(2):199-208. PubMed ID: 8596539 [TBL] [Abstract][Full Text] [Related]
31. Yeast RAD14 and human xeroderma pigmentosum group A DNA-repair genes encode homologous proteins. Bankmann M; Prakash L; Prakash S Nature; 1992 Feb; 355(6360):555-8. PubMed ID: 1741034 [TBL] [Abstract][Full Text] [Related]
32. Isolation by polymerase chain reaction of a cDNA whose product partially complements the ultraviolet sensitivity of xeroderma pigmentosum group C cells. Teitz T; Penner M; Eli D; Stark M; Bakhanashvili M; Naiman T; Canaani D Gene; 1990 Mar; 87(2):295-8. PubMed ID: 2332174 [TBL] [Abstract][Full Text] [Related]
33. Cloning and characterization of the mouse XPAC gene. van Oostrom CT; de Vries A; Verbeek SJ; van Kreijl CF; van Steeg H Nucleic Acids Res; 1994 Jan; 22(1):11-4. PubMed ID: 8127648 [TBL] [Abstract][Full Text] [Related]
34. Molecular studies of Japanese patients with group A xeroderma pigmentosum using polymerase chain reaction and restriction fragment length polymorphism and nonradioactive single strand conformation polymorphism analyses. Sumitani S; Ishikawa Y; Ishikawa Y; Minami R J Child Neurol; 1999 Mar; 14(3):168-72. PubMed ID: 10190268 [TBL] [Abstract][Full Text] [Related]
35. Analysis of the tumor suppressor gene p53 in xeroderma pigmentosum fibroblasts. Lavu S; Srivastava M; Srivastava SK Cancer Lett; 1994 Sep; 85(1):9-12. PubMed ID: 7923108 [TBL] [Abstract][Full Text] [Related]
36. Enhanced expression of mitochondrial genes in xeroderma pigmentosum fibroblast strains from various complementation groups. Rothe M; Werner D; Thielmann HW J Cancer Res Clin Oncol; 1993; 119(11):675-84. PubMed ID: 8394367 [TBL] [Abstract][Full Text] [Related]
37. Structure and expression of the human XPBC/ERCC-3 gene involved in DNA repair disorders xeroderma pigmentosum and Cockayne's syndrome. Weeda G; Ma LB; van Ham RC; van der Eb AJ; Hoeijmakers JH Nucleic Acids Res; 1991 Nov; 19(22):6301-8. PubMed ID: 1956789 [TBL] [Abstract][Full Text] [Related]
38. Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorean patients with Laron syndrome. Berg MA; Guevara-Aguirre J; Rosenbloom AL; Rosenfeld RG; Francke U Hum Mutat; 1992; 1(1):24-32. PubMed ID: 1284474 [TBL] [Abstract][Full Text] [Related]
39. Molecular cloning of a mouse DNA repair gene that complements the defect of group-A xeroderma pigmentosum. Tanaka K; Satokata I; Ogita Z; Uchida T; Okada Y Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5512-6. PubMed ID: 2748601 [TBL] [Abstract][Full Text] [Related]
40. A single-site mutation in the XPAC gene alters photoproduct recognition. McDowell ML; Nguyen T; Cleaver JE Mutagenesis; 1993 Mar; 8(2):155-61. PubMed ID: 8464385 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]